These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33542898)

  • 1. Treatment of Unresectable Differentiated Thyroid Carcinoma With Upfront External Radiotherapy and Salvage Surgery: A STROBE-Compliant Retrospective Cohort Study.
    Carrillo JF; Flores JM; Espinoza G; Vázquez-Romo R; Ramírez-Ortega MC; Carrillo LC; Cortés-García BY; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Front Oncol; 2020; 10():572958. PubMed ID: 33542898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute.
    Esmati E; Aleyasin A; Ghalehtaki R; Jafari F; Farhan F; Aghili M; Haddad P; Kazemian A
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1652. PubMed ID: 35691611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
    Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
    Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer.
    Groen AH; van Dijk D; Sluiter W; Links TP; Bijl HP; Plukker JTM
    Eur Thyroid J; 2022 Jan; 11(1):. PubMed ID: 34981752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.
    Sit D; Koh WX; Shokoohi A; Raycraft T; Vu M; Hamm J; Tran E; Berthelet E; Wu J; Olson R; Hamilton SN
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):468-478. PubMed ID: 34004228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Adjuvant External Beam Radiation Therapy for Nonanaplastic Thyroid Cancer in California, 2003-2017.
    Hu MY; Chin RK; Kim J; Tseng CH; Yeh MW; Livhits MJ; Leung AM; Wu JX
    Endocr Pract; 2022 Jul; 28(7):647-653. PubMed ID: 35231653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan.
    Kawamoto T; Yasuda K; Ito Y; Zenda S; Sakanaka K; Shikama N; Nakamura N; Mizowaki T
    Endocr J; 2023 Oct; 70(10):999-1003. PubMed ID: 37779083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.
    Pusceddu S; Prinzi N; Tafuto S; Ibrahim T; Filice A; Brizzi MP; Panzuto F; Baldari S; Grana CM; Campana D; Davì MV; Giuffrida D; Zatelli MC; Partelli S; Razzore P; Marconcini R; Massironi S; Gelsomino F; Faggiano A; Giannetta E; Bajetta E; Grimaldi F; Cives M; Cirillo F; Perfetti V; Corti F; Ricci C; Giacomelli L; Porcu L; Di Maio M; Seregni E; Maccauro M; Lastoria S; Bongiovanni A; Versari A; Persano I; Rinzivillo M; Pignata SA; Rocca PA; Lamberti G; Cingarlini S; Puliafito I; Ambrosio MR; Zanata I; Bracigliano A; Severi S; Spada F; Andreasi V; Modica R; Scalorbi F; Milione M; Sabella G; Coppa J; Casadei R; Di Bartolomeo M; Falconi M; de Braud F
    JAMA Netw Open; 2022 Feb; 5(2):e220290. PubMed ID: 35201309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
    White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
    Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer.
    Yin M; Zhao J; Monk P; Martin D; Folefac E; Joshi M; Jin N; Mortazavi A; Verschraegen C; Clinton S
    Cancer Med; 2020 Jan; 9(1):27-34. PubMed ID: 31697452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior survival benefits of Radical Prostatectomy than External Beam Radiotherapy in aging 75 and older men with high-risk or very high-risk Prostate Cancer: a population-matched study.
    Wang Y; Song P; Wang J; Shu M; Wang Q; Li Q
    J Cancer; 2020; 11(18):5371-5378. PubMed ID: 32742483
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.
    Kishan AU; Shaikh T; Wang PC; Reiter RE; Said J; Raghavan G; Nickols NG; Aronson WJ; Sadeghi A; Kamrava M; Demanes DJ; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    Eur Urol; 2017 May; 71(5):766-773. PubMed ID: 27452951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based Experience.
    Shokoohi A; Berthelet E; Gill S; Prisman E; Sexsmith G; Tran E; White A; Wiseman SM; Wu J; Ho C
    Cureus; 2020 Feb; 12(2):e7122. PubMed ID: 32257668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial.
    Sargos P; Mottet N; Bellera C; Richaud P
    BJU Int; 2020 Jun; 125(6):810-816. PubMed ID: 30946523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.
    Kishan AU; Steigler A; Denham JW; Zapatero A; Guerrero A; Joseph D; Maldonado X; Wong JK; Stish BJ; Dess RT; Pilar A; Reddy C; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Tran PT; Martin S; Martinez-Monge R; Krauss DJ; Abu-Isa EI; Pisansky TM; Choo CR; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Tilki D; Karnes RJ; Tosoian JJ; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Jiang T; Ma TM; Xiang M; Philipson R; Chang A; Kupelian PA; Rettig MB; Feng FY; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Boutros PC; Horwitz EM; Tendulkar RD; Spratt DE; Romero T
    JAMA Oncol; 2022 Mar; 8(3):e216871. PubMed ID: 35050303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.
    McGee HM; King MJ; Özbek U; Olson A; Kim E; Fischman AM; Schwartz M; Rosenzweig KE; Buckstein M
    Am J Clin Oncol; 2019 Apr; 42(4):367-374. PubMed ID: 30724782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
    Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
    Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.